G. Caleb Alexander, MD, MS

Professor
Johns Hopkins University, Department of Epidemiology

Poster(s):

• (A-085) Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-093) Comparative Safety and Effectiveness of Apixaban and Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolism: A Retrospective Cohort Study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-208) Development and Validation of a Modern Prescription-Based Risk Score Predicting Healthcare Spending and Utilization
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLA-003) Evaluating Effectiveness of Risk Minimization Through Healthcare Professional Education: A Literature Review
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (A-104) Heterogeneity of treatment effects of glucagon-like peptide-1 receptor agonists (GLP-1 RA's) for weight loss among adults: A systematic review and meta-analysis of randomized trials
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-106) Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1) on Weight Loss: A Retrospective Cohort Study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-125) Impact of GLP-1 Receptor Agonists versus DPP-4 Inhibitors and SGLT-2 Inhibitors on Asthma Exacerbations Among Individuals with Asthma and Type 2 Diabetes: A Target Trial Emulation Study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-297) Public Reporting of U.S. Food and Drug Administration Post-Marketing Requirement and Commitment (PMR/PMCs) on Drug Safety
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-047) Regulatory Flexibility in Drug Approval: A Comparative Analysis of U.S. Accelerated Approval and China’s Imported Drug Approval
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLA-035) Research and Development Costs for Biologic Products Developed by U.S. Biotechnology Startups, 2017-2023
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (C-103) Treatment of Type 2 Diabetes Among Medicare Beneficiaries With and Without Alzheimer’s Disease: A Retrospective Cohort Study
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-123) Use of Glucagon-like Peptide 1 Agonists (GLP-1's) Among Individuals Undergoing Bariatric Surgery In The United States: A Retrospective Cohort Study
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-083) Use of Statins for Primary Prevention among Individuals with Chronic Kidney Disease in The United States: A Cross-Sectional, Time-Trend Analysis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-086) Weight Changes from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) Use and Discontinuation: A Retrospective Cohort Study of Electronic Health Records
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET